References
- Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33(3):130-7; PMID:19464502; http://dx.doi.org/10.1053/j.semperi.2009.02.010
- Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008; 51(4):970-5; PMID:18259009; http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.107607
- Basso K, Dalla-Favera R. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis. Adv Immunol 2010; 105: 193-210; PMID:20510734; http://dx.doi.org/10.1016/S0065-2776(10)05007-8
- Louwen F, Muschol-Steinmetz C, Friemel A, Kämpf AK, Töttel E, Reinhard J, Yuan J. Targeted gene analysis: increased B-cell lymphoma 6 in preeclamptic placentas. Hum Pathol 2014; 45(6): 1234-42; PMID:24767250; http://dx.doi.org/10.1016/j.humpath.2014.02.002
- Muschol-Steinmetz C, et al. B-cell lymphoma 6 promotes proliferation and survival of trophoblastic cells. Cell Cycle 2016; In press
- Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009; 30 Suppl A:S32-7; PMID:19070896; http://dx.doi.org/10.1016/j.placenta.2008.11.009